Ulrik N Lassen (Ulrik Lassen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

JCO precision oncology

Nature genetics

Neuro-oncology

Cancer immunology research

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Copenhagen May 01 2015

Denmark

PHD :: Department of Oncology

Publications

Michela Riba, Cinzia Felicita Sala, Aedin C Culhane, Åsmund Flobak, Attila Patocs, Kjetil Boye, Karla Plevova, Sarka Pospisilova, Giorgia Gandolfi, Marco J Morelli, Gabriele Bucci, Anders Edsjö, Ulrik N Lassen, Fátima Al-Shahrour, Núria López-Bigas, Randi Hovland, Edwin Cuppen, Alfonso Valencia, Helene A Poirel, Richard Rosenquist, Serena Scollen, Juan Arenas Marquez, Jeroen A M Beliën, Arcangela De Nicolo, Ruggero De Maria, David Torrents, Giovanni Tonon
The 1+Million Genomes Minimal Dataset for Cancer. Nature genetics 56 (5) (2024)
Josephine D Hendriksen, Alessio Locallo, Simone Maarup, Olivia Debnath, Naveed Ishaque, Benedikte Hasselbalch, Jane Skjøth-Rasmussen, Christina Westmose Yde, Hans Skovgaard Poulsen, Ulrik N Lassen, Joachim Weischenfeldt
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients. Neuro-oncology 26 (8) (2024)
Michela Riba, Cinzia Felicita Sala, Aedin C Culhane, Åsmund Flobak, Attila Patocs, Kjetil Boye, Karla Plevova, Sarka Pospisilova, Giorgia Gandolfi, Marco J Morelli, Gabriele Bucci, Anders Edsjö, Ulrik N Lassen, Fátima Al-Shahrour, Núria López-Bigas, Randi Hovland, Edwin Cuppen, Alfonso Valencia, Helene A Poirel, Richard Rosenquist, Serena Scollen, Juan Arenas Marquez, Jeroen A M Beliën, Arcangela De Nicolo, Ruggero De Maria, David Torrents, Giovanni Tonon
The 1+Million Genomes Minimal Dataset for Cancer. Nature genetics 56 (5) (2024)
Josephine D Hendriksen, Alessio Locallo, Simone Maarup, Olivia Debnath, Naveed Ishaque, Benedikte Hasselbalch, Jane Skjøth-Rasmussen, Christina Westmose Yde, Hans Skovgaard Poulsen, Ulrik N Lassen, Joachim Weischenfeldt
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients. Neuro-oncology 26 (8) (2024)
Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways. Cancer immunology research 12 (9) (2024)
Dylan Scott Lykke Harwood, Vilde Pedersen, Nicolai Schou Bager, Ane Yde Schmidt, Tobias Overlund Stannius, Aušrinė Areškevičiūtė, Knud Josefsen, Dorte Schou Nørøxe, David Scheie, Hannah Rostalski, Maya Jeje Schuang Lü, Alessio Locallo, Ulrik N Lassen, Frederik Otzen Bagger, Joachim Weischenfeldt, Dieter Henrik Heiland, Kristoffer Vitting-Seerup, Signe Regner Michaelsen, Bjarne Winther Kristensen
Glioblastoma cells increase expression of notch signaling and synaptic genes within infiltrated brain tissue. Nature communications 15 (1) (2024)
Michela Riba, Cinzia Felicita Sala, Aedin C Culhane, Åsmund Flobak, Attila Patocs, Kjetil Boye, Karla Plevova, Sarka Pospisilova, Giorgia Gandolfi, Marco J Morelli, Gabriele Bucci, Anders Edsjö, Ulrik N Lassen, Fátima Al-Shahrour, Núria López-Bigas, Randi Hovland, Edwin Cuppen, Alfonso Valencia, Helene A Poirel, Richard Rosenquist, Serena Scollen, Juan Arenas Marquez, Jeroen A M Beliën, Arcangela De Nicolo, Ruggero De Maria, David Torrents, Giovanni Tonon
The 1+Million Genomes Minimal Dataset for Cancer. Nature genetics (2024)
Signe Koggersbøl Skadborg, Simone Maarup, Arianna Draghi, Annie Borch, Sille Hendriksen, Filip Mundt, Vilde Pedersen, Matthias Mann, Ib Jarle Christensen, Jane Skjøth-Rasmussen, Christina Westmose Yde, Bjarne Winther Kristensen, Hans Skovgaard Poulsen, Benedikte Hasselbalch, Inge Marie Svane, Ulrik N Lassen, Sine Reker Hadrup
Nivolumab reaches brain lesions in patients with recurrent glioblastoma and induces T-cell activity and upregulation of checkpoint pathways. Cancer immunology research (2024)
Carsten Bokemeyer, Noman Paracha, Ulrik N Lassen, Antoine Italiano, Sean D Sullivan, Marisca Marian, Nicoletta Brega, Jesús García-Foncillas
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data. JCO precision oncology 7 (2023)
Ulrik N Lassen, Carsten Bokemeyer, Jesús García-Foncillas, Antoine Italiano, Gilles Vassal, Noman Paracha, Marisca Marian, Yuxian Chen, Louise Linsell, Keith R Abrams
Prognostic Value of Neurotrophic Tyrosine Receptor Kinase Gene Fusions in Solid Tumors for Overall Survival: A Systematic Review and Meta-Analysis. JCO precision oncology 7 (2023)
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Anas Gazzah, Ulrik N Lassen, Alexander Stein, Patrick Y Wen, Sascha Dietrich, Maja J A de Jonge, Jean Yves Blay, Antoine Italiano, Kan Yonemori, Daniel C Cho, Filip Yves Francine De Vos, Philippe Moreau, Elena Elez Fernandez, Jan H M Schellens, Christoph C Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q Passos, Palanichamy Ilankumaran, Yung-Jue Bang
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nature medicine (2023)
Mette Kielsholm Thomsen, Katrine B Løppenthin, Pernille Envold Bidstrup, Elisabeth W Andersen, Susanne Oksbjerg Dalton, Lone N Petersen, Helle Pappot, Christiane E Mortensen, Mikkel Bring Christensen, Anne Frølich, Ulrik N Lassen, Christoffer Johansen
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017. Acta oncologica (Stockholm, Sweden) (2023)
Carsten Bokemeyer, Noman Paracha, Ulrik N Lassen, Antoine Italiano, Sean D Sullivan, Marisca Marian, Nicoletta Brega, Jesús García-Foncillas
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data. JCO precision oncology 7 (2023)
Alexander E Drilon, Daniel Shao-Weng Tan, Ulrik N Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D Patel, Lee S Rosen, Benjamin Solomon, Ricarda Norenberg, Laura Dima, Nicoletta Brega, Lin Shen, Victor Moreno, Shivaani Kummar, Jessica J Lin
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion-Positive Lung Cancers. JCO precision oncology 6 (2022)
Vladimir Lazar, Nicolas Girard, Eric Raymond, Jean-Francois Martini, Susan Galbraith, Jacques Raynaud, Catherine Bresson, Benjamin Solomon, Shai Magidi, Hovav Nechushtan, Amir Onn, Raanan Berger, Haiquan Chen, Amal Al-Omari, Sadakatsu Ikeda, Ulrik N Lassen, Marina Sekacheva, Enriqueta Felip Font, Josep Tabernero, Gerald Batist, Alan Spatz, Conjeevaram S Pramesh, Philippe Girard, Jean Yves Blay, Thierry Philip, Ioana Berindan Neagoe, Angel Porgador, Eitan Rubin, Razelle Kurzrock, Richard L Schilsky
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies. JCO precision oncology 6 (2022)
Antje Wick, Oliver Bähr, Martin Schuler, Kristoffer Staal Rohrberg, Sant P Chawla, Filip Janku, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz-Josef Lenz, Masafumi Ikeda, Yuichi Ando, Wolfgang Wick, Joachim P Steinbach, Michael C Burger, Katharina Johanna Wenger, Ulrik N Lassen, Kamalesh K Sankhala, Cristiana Roggia, Isabelle Genvresse, Catya Munhoz, Christine Rentzsch, Susanne Reschke, Simon Langer, Markus Wagner, Stefan Kaulfuss, Charles Cai, Eleni Lagkadinou, Michael Jeffers, Carol Peña, Ghazaleh Tabatabai
Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (10) (2021)
Ulrik N Lassen, Lydia E Makaroff, Albrecht Stenzinger, Antoine Italiano, Gilles Vassal, Jesus Garcia-Foncillas, Bernard Avouac
Precision oncology: a clinical and patient perspective. Future oncology (London, England) 17 (30) (2021)
Kristoffer Staal Rohrberg, Ulrik N Lassen
Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology. Drugs 81 (4) (2021)
Antoine Italiano, Shivani Nanda, Andrew Briggs, Jesus Garcia-Foncillas, Ulrik N Lassen, Gilles Vassal, Shivaani Kummar, Cornelis M van Tilburg, David S Hong, Theodore W Laetsch, Karen Keating, John A Reeves, Marc Fellous, Barrett H Childs, Alexander Drilon, David M Hyman
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis. Cancers 12 (11) (2020)
Bracha Shraibman, Eilon Barnea, Dganit Melamed Kadosh, Yael Haimovich, Gleb Slobodin, Itzhak Rosner, Carlos López-Larrea, Norbert Hilf, Sabrina Kuttruff, Colette Song, Cedrik Britten, John Castle, Sebastian Kreiter, Katrin Frenzel, Marcos Tatagiba, Ghazaleh Tabatabai, Pierre-Yves Dietrich, Valérie Dutoit, Wolfgang Wick, Michael Platten, Frank Winkler, Andreas von Deimling, Judith R Kroep, Juan Sahuquillo, Francisco Martínez-Ricarte, Jordi Rodon, Ulrik N Lassen, Christian Ottensmeier, Sjoerd H van der Burg, Per Thor Straten, Hans Skovgaard Poulsen, Berta Ponsati, Hideho Okada, Hans-Georg Rammensee, Ugur Sahin, Harpreet Singh, Arie Admon
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma. Molecular & cellular proteomics : MCP 17 (11) (2018)

Ulrik N Lassen.css-eqlu8i{font-size:small;padding-left:4px;} (Ulrik Lassen)

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrik N Lassen (Ulrik Lassen)